Clinical Study Site

Tokyo 135-8550

1 studies enrolling now · 3 studies all time

What they study most

Bleeding, Fabry Disease, Metastatic Colorectal Cancer (CRC)

Studies at this site

• Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer — Recruiting now
• A Study in Participants With Acute Major Bleeding to Evaluate the Ability of Andexanet Alfa to Reverse the Anticoagulation Effect of Direct and Indirect Oral Anticoagulants (Extension Study) — Completed
• Open-Label Extension Study of the Long-Term Effects of Migalastat HCL in Patients With Fabry Disease — Completed